RT combined with ICIs shows promising improvements in survival and tumor response compared to ICI alone in advanced HCC, albeit with increased toxicity. Large randomized trials are needed to confirm efficacy, optimize RT regimens, and identify patients most likely to benefit.
Building similarity graph...
Analyzing shared references across papers
Loading...
Hasnain Wajeeh Saqib
Mustafa Iqbal Khan
Tazeem Hayat
Asia-Pacific Journal of Clinical Oncology
Riphah International University
Dow University of Health Sciences
University College of Islamabad
Building similarity graph...
Analyzing shared references across papers
Loading...
Saqib et al. (Thu,) studied this question.
www.synapsesocial.com/papers/69db36c24fe01fead37c4bc3 — DOI: https://doi.org/10.1111/ajco.70116